Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1993 1
1994 13
1995 13
1996 7
1997 4
1998 11
1999 4
2000 1
2001 1
2002 1
2003 2
2004 7
2005 8
2006 17
2007 33
2008 52
2009 42
2010 49
2011 56
2012 41
2013 24
2014 23
2015 26
2016 35
2017 43
2018 39
2019 28
2020 39
2021 43
2022 40
2023 41
2024 49
2025 54
2026 48

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

782 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nakagomi a[au] (131 results)?
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai Hepatobiliary Oncology Group (KHBO). Ioka T, et al. Among authors: taketomi a. J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110. doi: 10.1002/jhbp.1219. Epub 2022 Aug 9. J Hepatobiliary Pancreat Sci. 2023. PMID: 35900311 Free PMC article. Clinical Trial.
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023.
Akahoshi K, Shindoh J, Tanabe M, Ariizumi S, Eguchi S, Okamura Y, Kaibori M, Kubo S, Shimada M, Taketomi A, Takemura N, Nagano H, Nakamura M, Hasegawa K, Hatano E, Yoshizumi T, Endo I, Kokudo N. Akahoshi K, et al. Among authors: taketomi a. Liver Cancer. 2024 Mar 29;13(6):0-10. doi: 10.1159/000538627. eCollection 2024 Dec. Liver Cancer. 2024. PMID: 39524972 Free PMC article.
NRF2-COX2-PGE 2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.
Yamamoto S, Kodama T, Kuwano A, Maesaka K, Yoshida-Hashidate T, Shindou H, Takeda H, Shirai K, Myojin Y, Murai K, Makino Y, Tahata Y, Saito Y, Hosui A, Nozaki Y, Nakabori T, Ohkawa K, Tanaka S, Nishio A, Miyazaki M, Hikita H, Motomura K, Lujambio A, Taketomi A, Eguchi H, Takehara T. Yamamoto S, et al. Among authors: taketomi a. Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001677. Online ahead of print. Hepatology. 2026. PMID: 41538242
Coccydynia Improved by Percutaneous Discectomy.
Kobayashi R, Okano I, Taketomi A, Hara E, Mera H. Kobayashi R, et al. Among authors: taketomi a. Cureus. 2024 Nov 27;16(11):e74564. doi: 10.7759/cureus.74564. eCollection 2024 Nov. Cureus. 2024. PMID: 39735113 Free PMC article.
Long non-coding RNA PWRN4 associated with post-SVR hepatocellular carcinoma: a genome-wide association study.
Suda G, Sugiyama M, Hikita H, Nishio A, Tatsumi T, Takehara T, Murakawa M, Nakagawa M, Asahina Y, Mizokami M, Kakisaka T, Sakamoto Y, Taketomi A, Miyanishi K, Ueno Y, Haga H, Maekawa S, Enomoto N, Kurosaki M, Kohjima M, Nakamuta M, Tanaka Y, Yamamoto Y, Baba M, Hanamatsu H, Furukawa JI, Ohara M, Kitagataya T, Kawagishi N, Nakai M, Sho T, Ogawa K, Sakamoto N. Suda G, et al. Among authors: taketomi a. Biomark Res. 2025 Sep 24;13(1):113. doi: 10.1186/s40364-025-00832-9. Biomark Res. 2025. PMID: 40993762 Free PMC article.
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal Cancer.
Bando H, Tsukada Y, Inamori K, Togashi Y, Koyama S, Kotani D, Fukuoka S, Yuki S, Komatsu Y, Homma S, Taketomi A, Uemura M, Kato T, Fukui M, Wakabayashi M, Nakamura N, Kojima M, Kawachi H, Kirsch R, Yoshida T, Suzuki Y, Sato A, Nishikawa H, Ito M, Yoshino T. Bando H, et al. Among authors: taketomi a. Clin Cancer Res. 2022 Mar 15;28(6):1136-1146. doi: 10.1158/1078-0432.CCR-21-3213. Clin Cancer Res. 2022. PMID: 35063964 Free PMC article.
PAGE4, upregulated in a novel iPSC-derived hepatoblastoma model, promotes hepatoblastoma progression.
Kawakita I, Honda S, Yamada Y, Tanaka S, Katayama Y, Shionoiri T, Ishii A, Kurosu H, Hamada K, Kumagai K, Nakazono K, Saito R, Terasaka C, Takahashi R, Kawahara I, Ara M, Iwasaki S, Tanaka S, Niida A, Hiyama E, Taketomi A, Taniguchi K. Kawakita I, et al. Among authors: taketomi a. Biochem Biophys Res Commun. 2025 Nov 19;790:152824. doi: 10.1016/j.bbrc.2025.152824. Epub 2025 Oct 16. Biochem Biophys Res Commun. 2025. PMID: 41172808
Human Leukocyte Antigen Genotypes Affect Hepatitis B Virus Mutations Associated With Hepatocellular Carcinoma.
Sugiyama M, Nishida N, Khor SS, Shin-I T, Hino K, Honda M, Kaneko S, Yatsuhashi H, Koike K, Kurosaki M, Izumi N, Tanaka Y, Murata K, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Suda G, Sakamoto N, Yamamoto K, Tamori A, Hige S, Itoh Y, Mochida S, Mita E, Ide T, Hiasa Y, Watanabe M, Yamamoto K, Sakai A, Wakita T, Mizokami M, Tokunaga K. Sugiyama M, et al. Among authors: taketomi a. Hepatol Res. 2025 Nov;55(11):1445-1453. doi: 10.1111/hepr.70007. Epub 2025 Jul 29. Hepatol Res. 2025. PMID: 40728240
782 results